This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
| adjective | noun | frequency |
|---|---|---|
| whole | blood | 193 |
| red | blood | 169 |
| red | cell | 121 |
| - | hev | 114 |
| acute | hepatitis | 64 |
| red | cells | 64 |
| chronic | hepatitis | 57 |
| - | transfusion | 51 |
| present | study | 43 |
| - | cell | 38 |
| viral | hepatitis | 37 |
| positive | . | 34 |
| negative | . | 34 |
| - | risk | 34 |
| - | infection | 31 |
| humans | . | 31 |
| - | e | 30 |
| high | risk | 29 |
| positive | samples | 28 |
| significant | . | 24 |
| chronic | hev | 23 |
| higher | risk | 23 |
| positive | donations | 21 |
| specific | antibodies | 21 |
| positive | results | 21 |
| available | . | 21 |
| human | hepatitis | 21 |
| - | donation | 21 |
| - | protein | 21 |
| chronic | infection | 20 |
| - | level | 19 |
| viral | infections | 19 |
| - | analysis | 18 |
| new | donors | 17 |
| human | hev | 15 |
| viral | proteins | 15 |
| positive | donors | 14 |
| clinical | samples | 14 |
| - | cells | 13 |
| different | blood | 13 |
| - | infections | 12 |
| human | cells | 12 |
| other | studies | 12 |
| - | platelet | 11 |
| clinical | cases | 11 |
| high | level | 11 |
| viral | infection | 11 |
| human | infection | 10 |
| several | studies | 10 |
| clinical | data | 10 |
| chronic | infections | 10 |
| - | blood | 9 |
| clinical | studies | 9 |
| clinical | transfusion | 9 |
| different | hev | 9 |
| other | blood | 9 |
| positive | result | 9 |
| - | antibodies | 9 |
| positive | patients | 8 |
| negative | results | 8 |
| new | blood | 8 |
| negative | samples | 8 |
| molecular | methods | 8 |
| negative | donors | 8 |
| negative | blood | 8 |
| human | blood | 8 |
| low | level | 7 |
| significant | risk | 7 |
| molecular | analysis | 7 |
| present | . | 7 |
| human | platelet | 7 |
| highest | risk | 7 |
| high | . | 7 |
| human | cases | 6 |
| same | group | 6 |
| same | blood | 6 |
| positive | group | 6 |
| positive | blood | 6 |
| other | groups | 6 |
| human | viruses | 6 |
| human | samples | 6 |
| - | patients | 6 |
| higher | hev | 6 |
| high | sequence | 6 |
| high | levels | 6 |
| first | blood | 6 |
| acute | infections | 6 |
| acute | infection | 6 |
| acute | hev | 6 |
| - | virus | 6 |
| positive | antibody | 5 |
| other | viruses | 5 |
| others | . | 5 |
| negative | group | 5 |
| presented | . | 5 |
| such | cases | 5 |
| other | risk | 5 |
| positive | cases | 5 |
| low | levels | 5 |
| highest | level | 5 |
| higher | platelet | 5 |
| - | donor | 5 |
| high | hev | 5 |
| different | cell | 5 |
| human | cell | 5 |
| positive | patient | 4 |
| negative | result | 4 |
| new | donor | 4 |
| new | hepatitis | 4 |
| new | hev | 4 |
| other | virus | 4 |
| similar | . | 4 |
| same | results | 4 |
| several | viruses | 4 |
| significant | antibodies | 4 |
| lower | levels | 4 |
| similar | results | 4 |
| specific | antibody | 4 |
| negative | donor | 4 |
| other | . | 4 |
| lower | . | 4 |
| human | case | 4 |
| low | platelet | 4 |
| anti | hev | 4 |
| available | data | 4 |
| different | . | 4 |
| different | levels | 4 |
| human | antibody | 4 |
| first | study | 4 |
| human | infections | 4 |
| important | . | 4 |
| large | platelets | 4 |
| low | . | 4 |
| low | blood | 4 |
| low | hev | 4 |
| same | level | 3 |
| other | infections | 3 |
| other | sequences | 3 |
| positive | cells | 3 |
| positive | donor | 3 |
| positive | hev | 3 |
| present | results | 3 |
| same | donor | 3 |
| specific | blood | 3 |
| same | study | 3 |
| same | virus | 3 |
| several | cases | 3 |
| several | samples | 3 |
| significant | antibody | 3 |
| significant | blood | 3 |
| specific | cell | 3 |
| viral | protein | 3 |
| new | virus | 3 |
| other | donors | 3 |
| molecular | level | 3 |
| new | cases | 3 |
| different | sample | 3 |
| negative | patients | 3 |
| - | antibody | 3 |
| - | platelets | 3 |
| acute | cases | 3 |
| available | blood | 3 |
| clinical | case | 3 |
| different | platelet | 3 |
| - | groups | 3 |
| different | virus | 3 |
| lower | risk | 3 |
| high | donor | 3 |
| high | platelet | 3 |
| higher | levels | 3 |
| human | platelets | 3 |
| larger | studies | 3 |
| first | transfusion | 3 |
| same | method | 2 |
| same | cell | 2 |
| present | analysis | 2 |
| present | analyses | 2 |
| positive | sample | 2 |
| other | samples | 2 |
| other | hev | 2 |
| other | risks | 2 |
| other | proteins | 2 |
| other | platelet | 2 |
| other | cell | 2 |
| new | studies | 2 |
| new | platelet | 2 |
| new | method | 2 |
| same | patients | 2 |
| specific | group | 2 |
| same | sample | 2 |
| same | samples | 2 |
| several | hev | 2 |
| several | methods | 2 |
| several | virus | 2 |
| significant | sequence | 2 |
| similar | sequence | 2 |
| specific | . | 2 |
| specific | groups | 2 |
| specific | methods | 2 |
| specific | risk | 2 |
| such | antibodies | 2 |
| such | studies | 2 |
| whole | study | 2 |
| whole | virus | 2 |
| new | methods | 2 |
| highest | virus | 2 |
| new | antibody | 2 |
| higher | case | 2 |
| molecular | studies | 2 |
| - | donors | 2 |
| - | group | 2 |
| - | sequence | 2 |
| chronic | transfusion | 2 |
| different | antibody | 2 |
| different | donors | 2 |
| different | groups | 2 |
| different | proteins | 2 |
| different | studies | 2 |
| first | case | 2 |
| first | donation | 2 |
| first | group | 2 |
| higher | . | 2 |
| different | patient | 2 |
| higher | risks | 2 |
| larger | study | 2 |
| molecular | results | 2 |
| human | . | 2 |
| molecular | data | 2 |
| molecular | analyses | 2 |
| lower | sequence | 2 |
| low | risk | 2 |
| low | virus | 2 |
| larger | sample | 2 |
| large | blood | 2 |
| large | . | 2 |
| important | viruses | 2 |
| important | blood | 2 |
| human | antibodies | 2 |
| newer | studies | 1 |
| other | patient | 1 |
| other | antibodies | 1 |
| other | cases | 1 |
| other | cells | 1 |
| other | data | 1 |
| other | methods | 1 |
| presented | data | 1 |
| other | studied | 1 |
| other | transfusion | 1 |
| positive | cell | 1 |
| positive | donation | 1 |
| positive | hepatitis | 1 |
| present | studies | 1 |
| new | risks | 1 |
| new | study | 1 |
| more | results | 1 |
| new | risk | 1 |
| new | patients | 1 |
| new | cells | 1 |
| new | antibodies | 1 |
| negative | sample | 1 |
| negative | groups | 1 |
| negative | donations | 1 |
| negative | donation | 1 |
| negative | cells | 1 |
| negative | case | 1 |
| negative | antibody | 1 |
| more | viruses | 1 |
| more | studies | 1 |
| more | samples | 1 |
| same | donors | 1 |
| red | . | 1 |
| similar | samples | 1 |
| same | patient | 1 |
| such | patients | 1 |
| such | analysis | 1 |
| such | blood | 1 |
| such | cells | 1 |
| such | data | 1 |
| such | donors | 1 |
| such | infections | 1 |
| such | sequences | 1 |
| specific | sequences | 1 |
| viral | risk | 1 |
| viral | samples | 1 |
| viral | sequence | 1 |
| viral | sequences | 1 |
| viral | transfusion | 1 |
| viral | viruses | 1 |
| specific | viruses | 1 |
| specific | results | 1 |
| same | platelet | 1 |
| significant | level | 1 |
| same | result | 1 |
| same | risk | 1 |
| same | sequences | 1 |
| several | groups | 1 |
| several | patients | 1 |
| several | platelet | 1 |
| similar | blood | 1 |
| specific | analysis | 1 |
| similar | donation | 1 |
| similar | hev | 1 |
| similar | levels | 1 |
| similar | method | 1 |
| similar | result | 1 |
| more | hev | 1 |
| more | infections | 1 |
| large | hepatitis | 1 |
| more | groups | 1 |
| first | . | 1 |
| clinical | platelet | 1 |
| clinical | results | 1 |
| clinical | risk | 1 |
| different | cells | 1 |
| different | donor | 1 |
| different | methods | 1 |
| first | cell | 1 |
| clinical | . | 1 |
| first | data | 1 |
| first | donor | 1 |
| first | results | 1 |
| first | sample | 1 |
| first | studied | 1 |
| first | studies | 1 |
| clinical | blood | 1 |
| chronic | transfusions | 1 |
| more | donors | 1 |
| - | sequenced | 1 |
| - | analyses | 1 |
| - | case | 1 |
| - | data | 1 |
| - | hepatitis | 1 |
| - | patient | 1 |
| - | proteins | 1 |
| - | studied | 1 |
| chronic | patients | 1 |
| - | viruses | 1 |
| acute | blood | 1 |
| acute | patients | 1 |
| available | sequences | 1 |
| available | studies | 1 |
| chronic | blood | 1 |
| first | viruses | 1 |
| high | antibody | 1 |
| high | blood | 1 |
| largest | level | 1 |
| large | groups | 1 |
| large | sample | 1 |
| large | study | 1 |
| larger | samples | 1 |
| largest | blood | 1 |
| largest | group | 1 |
| low | patients | 1 |
| higher | antibody | 1 |
| lower | level | 1 |
| lower | platelet | 1 |
| molecular | blood | 1 |
| more | cases | 1 |
| more | data | 1 |
| more | donations | 1 |
| important | transfusion | 1 |
| important | study | 1 |
| important | studies | 1 |
| important | risk | 1 |
| important | protein | 1 |
| important | data | 1 |
| humans | risk | 1 |
| humans | e | 1 |
| human | patients | 1 |
| human | patient | 1 |
| human | donor | 1 |
| highest | platelet | 1 |
| highest | hev | 1 |
| highest | blood | 1 |
| higher | level | 1 |
| higher | donor | 1 |
| higher | donation | 1 |
| whole | . | 1 |